Shared on 05 Sep 25
Fair value Decreased 0.40%MedPlus Health Services’ fair value has seen a marginal downward revision to ₹1,060 as analysts respond to a sharp rise in future P/E and a notable decline in net profit margin. What's in the News Board meeting scheduled for Aug 02 to review and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, and to consider other matters.
Shared on 15 Jul 25
Fair value Increased 10%Despite lower consensus revenue growth forecasts, MedPlus Health Services’ sharply improved net profit margin has driven a notable increase in the consensus analyst price target from ₹965.39 to ₹1064. Valuation Changes Summary of Valuation Changes for MedPlus Health Services The Consensus Analyst Price Target has significantly risen from ₹965.39 to ₹1064.
Shared on 01 May 25
Fair value Decreased 0.47%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 0.87%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 13 Mar 25
Fair value Decreased 9.63%AnalystConsensusTarget made no meaningful changes to valuation assumptions.